1. Home
  2. STSS vs MIRA Comparison

STSS vs MIRA Comparison

Compare STSS & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sharps Technology Inc.

STSS

Sharps Technology Inc.

HOLD

Current Price

$1.84

Market Cap

43.8M

Sector

Health Care

ML Signal

HOLD

Logo MIRA Pharmaceuticals Inc.

MIRA

MIRA Pharmaceuticals Inc.

HOLD

Current Price

$1.04

Market Cap

43.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STSS
MIRA
Founded
2017
2020
Country
United States
United States
Employees
55
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.8M
43.7M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
STSS
MIRA
Price
$1.84
$1.04
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
374.7K
127.7K
Earning Date
04-06-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.42
$0.90
52 Week High
$18.23
$2.45

Technical Indicators

Market Signals
Indicator
STSS
MIRA
Relative Strength Index (RSI) 53.34 45.10
Support Level $1.66 $0.99
Resistance Level $2.00 $1.24
Average True Range (ATR) 0.08 0.05
MACD 0.00 0.00
Stochastic Oscillator 43.75 17.86

Price Performance

Historical Comparison
STSS
MIRA

About STSS Sharps Technology Inc.

Sharps Technology Inc is a medical device and pharmaceutical packaging company offering patented, smart-safety syringe products to the healthcare industry. The Company's product lines focus on providing ultra-low waste capabilities that incorporate syringe technologies that use both passive and active safety features. The Company has adopted a digital asset treasury scheme focused on accumulating SOL, the native digital asset of the Solana blockchain, leveraging capital markets raises to power on-chain yield generation with the Solana Ecosystem.

About MIRA MIRA Pharmaceuticals Inc.

Mira Pharmaceuticals Inc is a clinical-stage pharmaceutical development company focused on developing novel oral small-molecule therapeutics for neurologic, neuropsychiatric, metabolic, and inflammatory disorders. The company's pipeline includes three product candidates: Ketamir-2, MIRA-55, and SKNY-1, three drug candidates designed to address unmet medical needs across neuropathic and inflammatory pain, central nervous system disorders, and metabolic and behavioral conditions. The company operates as a single operating and reportable segment.

Share on Social Networks: